Replies to post #121 on Optimer Pharmaceuticals, Inc. (OPTR)

[kris_kade]

From the PR today, looks like OPTR's drug DIFICID will eat Vancomycin's lunch !!

http://finance.yahoo.com/news/Data-Presented-at-Digestive-prnews-4057287648.html?x=0&.v=1